GSK Investigational Site
Madrid, Spain
1,342 recruiting
Showing 1–20 of 81 trials
Recruiting
Phase 1Phase 2
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Neoplasms, Prostate
GlaxoSmithKline54 enrolled8 locationsNCT07332455
Recruiting
Phase 1Phase 2
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
Neoplasms, Prostate
GlaxoSmithKline85 enrolled19 locationsNCT06990880
Recruiting
Phase 1Phase 2
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
NeoplasmsNeoplasms, Colorectal
GlaxoSmithKline47 enrolled19 locationsNCT07213609
Recruiting
Phase 3
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Gastrointestinal Neoplasms
GlaxoSmithKline450 enrolled124 locationsNCT07218926
Recruiting
Phase 2
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
Bronchiectasis
GlaxoSmithKline446 enrolled39 locationsNCT07201051
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Multiple Myeloma
GlaxoSmithKline200 enrolled27 locationsNCT07227311
Recruiting
Phase 1
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
Non-Alcoholic Fatty Liver Disease
GlaxoSmithKline32 enrolled3 locationsNCT07358546
Recruiting
Phase 4
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
GlaxoSmithKline350 enrolled114 locationsNCT06411249
Recruiting
Phase 2
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
Myelodysplastic Syndromes
GlaxoSmithKline80 enrolled39 locationsNCT06847867
Recruiting
Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Chickenpox
GlaxoSmithKline1,840 enrolled97 locationsNCT06740630
Recruiting
Phase 3
A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age
Chickenpox
GlaxoSmithKline600 enrolled6 locationsNCT06806137
Recruiting
Phase 3
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
Chickenpox
GlaxoSmithKline750 enrolled46 locationsNCT06693895
Recruiting
Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
Chickenpox
GlaxoSmithKline911 enrolled22 locationsNCT06855160
Recruiting
Phase 3
A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease
Respiratory Syncytial Virus Infections
GlaxoSmithKline750 enrolled15 locationsNCT07220109
Recruiting
Phase 3
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
HIV Infections
ViiV Healthcare332 enrolled89 locationsNCT06694805
Recruiting
Phase 1
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
Neoplasms
GlaxoSmithKline97 enrolled8 locationsNCT07438782
Recruiting
Phase 3
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
Neoplasms, Lung
GlaxoSmithKline420 enrolled120 locationsNCT07099898
Recruiting
Phase 2
A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
Neoplasms, Colon
GlaxoSmithKline120 enrolled33 locationsNCT06567782
Recruiting
Phase 1Phase 2
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Multiple Myeloma
GlaxoSmithKline152 enrolled30 locationsNCT05714839
Recruiting
Phase 3
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Neoplasms, Head and Neck
GlaxoSmithKline864 enrolled277 locationsNCT06256588